2-(R)-Cyclohexyl-N-(2-{4-[5-(2,3-dichloro-phenyl)-2H-pyrazol-3-yl]-piperidin-1-yl}-2-oxo-ethyl)-2-guanidino-acetamide

ID: ALA106187

Chembl Id: CHEMBL106187

PubChem CID: 447945

Max Phase: Preclinical

Molecular Formula: C25H33Cl2N7O2

Molecular Weight: 534.49

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)N[C@@H](C(=O)NCC(=O)N1CCC(c2cc(-c3cccc(Cl)c3Cl)n[nH]2)CC1)C1CCCCC1

Standard InChI:  InChI=1S/C25H33Cl2N7O2/c26-18-8-4-7-17(22(18)27)20-13-19(32-33-20)15-9-11-34(12-10-15)21(35)14-30-24(36)23(31-25(28)29)16-5-2-1-3-6-16/h4,7-8,13,15-16,23H,1-3,5-6,9-12,14H2,(H,30,36)(H,32,33)(H4,28,29,31)/t23-/m1/s1

Standard InChI Key:  SSSXBBASYYVGCI-HSZRJFAPSA-N

Associated Targets(Human)

IL2 Tchem Interleukin-2 (144 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Il2ra Interleukin-2 receptor alpha chain (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 534.49Molecular Weight (Monoisotopic): 533.2073AlogP: 3.64#Rotatable Bonds: 7
Polar Surface Area: 139.99Molecular Species: BASEHBA: 4HBD: 5
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.85CX Basic pKa: 11.42CX LogP: 2.89CX LogD: 0.63
Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.27Np Likeness Score: -1.24

References

1. Raimundo BC, Oslob JD, Braisted AC, Hyde J, McDowell RS, Randal M, Waal ND, Wilkinson J, Yu CH, Arkin MR..  (2004)  Integrating fragment assembly and biophysical methods in the chemical advancement of small-molecule antagonists of IL-2: an approach for inhibiting protein-protein interactions.,  47  (12): [PMID:15163192] [10.1021/jm049967u]
2. Waal ND, Yang W, Oslob JD, Arkin MR, Hyde J, Lu W, McDowell RS, Yu CH, Raimundo BC..  (2005)  Identification of nonpeptidic small-molecule inhibitors of interleukin-2.,  15  (4): [PMID:15686897] [10.1016/j.bmcl.2004.12.045]
3. Kalsoom S, Rashid U, Shaukat A, Abdalla OM, Hussain K, Khan W, Nazir S, Mesaik MA, Zaheer-ul-Haq, Ansari FL.  (2013)  In vitro and in silico exploration of IL-2 inhibition by small drug-like molecules,  22  (12): [10.1007/s00044-013-0564-x]

Source